Glenmark Pharmaceuticals informs about media release

28 Jan 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed a media release on 28th January 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg’ which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2133.30 -37.20 (-1.71%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×